Delisting risk
Retractable Technologies
Makes retractable syringes, safety needles, and blood-collection devices.
$0.7350
After-hours close+0.02 (+2.78%)
At close$0.7151(−0.93%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 8.81%Insiders —
Shares outstanding 29.94M · Float 12.21M · 40.8% free float
Institutions13F, as of Jun 30, 2026
33 holders · 2.64M shares · 4 new positions · 10 increased · 4 reduced · 2 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Vanguard Capital Management LLC | 581.7K | 1.94% | 0 | Aug 13, 2026 |
| Eversept Partners, LP | 580.9K | 1.94% | 0 | Aug 14, 2026 |
| Renaissance Technologies LLC | 441.4K | 1.47% | +37.4K | Aug 13, 2026 |
| BlackRock, Inc. | 241.1K | 0.81% | −1 | Aug 7, 2026 |
| Geode Capital Management, LLC | 121.0K | 0.40% | −28.4K | Aug 12, 2026 |
| Bridgeway Capital Management, LLC | 88.5K | 0.30% | 0 | Aug 14, 2026 |
| Citadel Advisors LLC | 87.3K | 0.29% | +87.3K | Aug 14, 2026 |
| Vanguard Fiduciary Trust Co | 85.3K | 0.28% | 0 | Aug 13, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Thomas J. Shaw | 55.00% | 16.48M | 13D | Aug 29, 2025 ↗ |
InsidersForm 4
Latest trades
Nothing filed in the last 12 months.
CongressHouse and Senate disclosures
Not reported.